Histogen Inc logo

Histogen Inc

OTCPK:HSTO (USA)  
$ 0.36 -0.0399 (-9.98%) 11:09 PM EST
At Loss
P/B:
0.28
Enterprise V:
$ -2.86M
Volume:
5.15K
Avg Vol (2M):
21.32K
Also Trade In:
Volume:
5.15K
At Loss
Avg Vol (2M):
21.32K

Business Description

Description
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
Name Current Vs Industry Vs History
Cash-To-Debt 1.01
Equity-to-Asset 0.94
Debt-to-Equity 0.83
Debt-to-EBITDA -0.37
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -29.1
Distress
Grey
Safe
Beneish M-Score -38.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.16
9-Day RSI 49.72
14-Day RSI 50.63
6-1 Month Momentum % -38.25
12-1 Month Momentum % -72.12

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.05
Quick Ratio 4.05
Cash Ratio 3.39
Days Sales Outstanding 1363.95

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -93.4
Shareholder Yield % 12.18

Financials (Next Earnings Date:2024-05-10 Est.)

HSTO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:HSTO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Histogen Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.019
EPS (TTM) ($) -2.81
Beta 1.83
Volatility % 59.02
14-Day RSI 50.63
14-Day ATR ($) 0.034334
20-Day SMA ($) 0.358005
12-1 Month Momentum % -72.12
52-Week Range ($) 0.275 - 1.3
Shares Outstanding (Mil) 4.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Histogen Inc Filings

Filing Date Document Date Form
No Filing Data

Histogen Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Histogen Inc Frequently Asked Questions

What is Histogen Inc(HSTO)'s stock price today?
The current price of HSTO is $0.36. The 52 week high of HSTO is $1.30 and 52 week low is $0.28.
When is next earnings date of Histogen Inc(HSTO)?
The next earnings date of Histogen Inc(HSTO) is 2024-05-10 Est..
Does Histogen Inc(HSTO) pay dividends? If so, how much?
Histogen Inc(HSTO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1